Phathom Pharmaceuticals, Inc. PHAT Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $180.9M+39.2% | $129.97M-3.8% | $135.16M-9.6% | $149.57M-29.6% | $212.32M-28.6% | ||
| $265.9M+20.0% | $221.54M+21.6% | $182.21M+23.6% | $147.47M+37.7% | $107.09M+43.5% | ||
| $88.58M-4.3% | $92.52M+11.0% | $83.33M+27.4% | $65.41M+36.5% | $47.9M+43.9% | ||
| $276.57M+20.8% | $228.97M+10.2% | $207.78M-5.1% | $218.88M-17.4% | $264.9M-26.4% | ||
| $1.02M-4.5% | $1.06M-8.0% | $1.16M-6.9% | $1.24M-8.3% | $1.35M-8.3% | ||
| $305.12M+17.7% | $259.15M+7.8% | $240.29M-4.0% | $250.22M-15.0% | $294.21M-22.2% | ||
| $6.37M+27.7% | $4.98M+364% | $1.08M-73.2% | $4.01M-65.5% | $11.62M+10.6% | ||
| $33.02M+21.2% | $27.25M+11.9% | $24.34M+13.1% | $21.53M+24.7% | $17.27M-12.7% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $125.04M-5.3% | $132.04M+41.8% | $93.12M+1.4% | $91.82M+24.0% | $74.03M-13.6% | ||
| $163.68M-21.7% | $209.09M+1.0% | $207.09M+1.0% | $205.14M+0.9% | $203.25M+0.9% | ||
| $642.08M-7.9% | $697.32M+5.2% | $662.82M+1.0% | $656.05M+3.7% | $632.58M+0.1% | ||
| $7K+16.7% | $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | ||
| -$1.51B-2.0% | -$1.48B-1.4% | -$1.46B-2.1% | -$1.43B-5.6% | -$1.36B-7.5% | ||
| -$336.96M+23.1% | -$438.17M-3.7% | -$422.53M-4.1% | -$405.83M-19.9% | -$338.38M-33.4% | ||
| $305.12M+17.7% | $259.15M+7.8% | $240.29M-4.0% | $250.22M-15.0% | $294.21M-22.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Phathom Pharmaceuticals, Inc.'s total assets?
- Phathom Pharmaceuticals, Inc. (PHAT) holds $305.1M in total assets, up 3.7% year over year.
- How much debt does Phathom Pharmaceuticals, Inc. have?
- Phathom Pharmaceuticals, Inc. carries $166.3M in total debt against -$337.0M of shareholders' equity, a debt-to-equity ratio of 5.64.
- How much cash does Phathom Pharmaceuticals, Inc. have?
- Phathom Pharmaceuticals, Inc. holds $180.9M in cash and equivalents.
- Can Phathom Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 2.21 — current assets exceed current liabilities.
- Where does Phathom Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Phathom Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
